Results obtained from preclinical studies and controlled trials on healthy volunteers and individuals with mild cognitive impairment or Alzheimer’s disease have supported the potential of intranasal insulin in improving memory performance [113]. Here, INS is linked to early-onset autosomal dominant Alzheimer disease.